LifeMD (LFMD) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenue reached $50.2 million, exceeding guidance, with over 42,000 net telehealth subscriber additions and 365,000+ active subscribers, driven by record growth in GLP-1 and women's health sign-ups.

• Platform delivered end-to-end virtual care, pharmacy, and diagnostics nationwide, with 1.95M+ unique monthly visitors and 98% patient satisfaction.

• Strategic investments in AI, pharmacy, and insurance infrastructure are positioning the platform for scalable, durable growth and a shift to a comprehensive virtual healthcare platform.

• The company completed the sale of its WorkSimpli subsidiary in late 2025, focusing exclusively on virtual healthcare and pharmacy services.

Financial highlights

• Revenue was $50.2 million, flat year-over-year, with gross profit up 3% to $44.2 million and gross margin expanding to 88% from 84% due to improved shipping and fulfillment costs.

• Selling and marketing expenses increased 34% year-over-year to $29.9 million, representing 60% of revenue, due to front-loaded patient acquisition investments.

• GAAP net loss from continuing operations was $9.6 million ($0.20 per share), compared to $2.4 million ($0.06 per share) last year.

• Adjusted EBITDA loss was $4.5 million, in line with guidance, versus a $3.7 million gain last year.

• Ended Q1 with $34.5 million in cash, no debt, and a $30 million undrawn credit facility.

Outlook and guidance

• Reaffirmed 2026 full-year revenue guidance of $220–$230 million (13–19% growth) and adjusted EBITDA of $12–$17 million.

• Expects to return to adjusted EBITDA profitability in the second half of 2026 as acquisition costs decline and Q1 patient volumes become accretive.

• Q2 revenue expected between $47–$50 million and adjusted EBITDA between -$2 million and +$1 million.

• Annualized run rate revenue projected above $250 million and adjusted EBITDA above $25 million by Q4 2026.

• Management expects existing cash and proceeds from ATM equity sales to fund operations and capital needs for at least the next 12 months.